Cargando…
Pulmonary hypertension in patients with chronic myeloid leukemia
Dasatinib, a tyrosine kinase inhibitor (TKI), induces pulmonary hypertension (PH) in patients with chronic myeloid leukemia (CML). However, information on other TKIs is limited. We retrospectively analyzed PH prevalence by reviewing transthoracic echocardiography (TTE) findings in a population of Ko...
Autores principales: | Song, Ik-Chan, Yeon, Sang-Hoon, Lee, Myeong-Won, Ryu, Hyewon, Lee, Hyo-Jin, Yun, Hwan-Jung, Sun, Byung Joo, Park, Jae-Hyeong, Jeong, Jin-Ok, Jo, Deog-Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376321/ https://www.ncbi.nlm.nih.gov/pubmed/34414970 http://dx.doi.org/10.1097/MD.0000000000026975 |
Ejemplares similares
-
A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation
por: Lee, Myung-Won, et al.
Publicado: (2020) -
Clinical features and outcomes of hypocellular acute myeloid leukemia in adults: A Korean AML registry data
por: Song, Ik-Chan, et al.
Publicado: (2021) -
Pulmonary hypertension in patients with Philadelphia-negative myeloproliferative neoplasms: a single-center retrospective analysis of 225 patients
por: Lee, Myeong-Won, et al.
Publicado: (2020) -
Occurrence of lymphoplasmacytic lymphoma in a chronic myeloid leukemia patient following long-term treatment with tyrosine kinase inhibitors: A case report
por: Lee, Chang-Hoon, et al.
Publicado: (2020) -
Clinical insights into hematologic malignancies and comparative analysis of molecular signatures of acute myeloid leukemia in different ethnicities using an artificial intelligence offering
por: Snowdon, Jane L., et al.
Publicado: (2021)